A Phase II Trial of G01 Eye Drops for Glaucomatous Optic Neuropathy | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Phase II Trial of G01 Eye Drops for Glaucomatous Optic Neuropathy	Cranial Nerve Injuries, Craniocerebral Trauma, cranial nerve neuropathy, eye disorder, glaucoma, injury, nervous system disorder, nervous system injury, ocular hypertension, open-angle glaucoma, optic nerve disorder, traumatic optic neuropathy	Recruiting	Phase 2	2026-08-24		NCT07777861

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Qingdao WanMing BioCell Pharmaceutics Co.,Ltd.	1

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Beijing Tongren Hospital, Capital Medical University	Beijing	China	11
Eye Hospital, Wenzhou Medical University	Wenzhou	China	1
Joint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong	Shantou	China	2
Peking University First Hospital	Beijing	China	41
Peking University Third Hospital	Beijing	China	38
The Second Affiliated Hospital, Zhejiang University School of Medicine	Hangzhou	China	10
Tianjin Eye Hospital	Tianjin	China	5
Xiangya Hospital of Central South University	Changsha	China	36
Zhongshan Ophthalmic Center, Sun Yat-sen University	Guangzhou	China	6